Proffered Paper 2 – Gynaecological cancers
Proffered Paper 2 – Gynaecological cancers - Invited Discussant LBA62 and 994O
Date
29 Sep 2019Session
Proffered Paper 2 – Gynaecological cancersPresenters
Nicoletta ColomboAuthors
N. ColomboAuthor affiliations
- Gynecologic Oncology Dept., Istituto Europeo di Oncologia, 20141 - Milan/IT
Resources
Resources from the same session
4093 - FORWARD I (GOG 3011): A Phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
Presenter: Kathleen Moore
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
4101 - Lenvatinib (LEN) and Pembrolizumab (PEMBRO) in Advanced Endometrial Cancer (EC)
Presenter: Vicky Makker
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
2738 - A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian or Peritoneal Cancer
Presenter: David Gershenson
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Gynaecological cancers - Invited Discussant 992O and LBA61
Presenter: Jonathan Ledermann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Slides
Webcast
5630 - Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
Presenter: Robert Naumann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.